QUICK SNAPSHOT

MOTS-c

Metabolic & Longevity

Regulatory · Apr 2026 Under PCAC review July 23-24, 2026 for possible §503A Bulks List inclusion. Read more →
FDA Status
Not FDA-Approved
Claimed Benefits
  • Metabolic regulation / exercise mimetic (animal)
  • Bone formation (animal)
  • Muscle preservation (animal)
Clinical Evidence

No Published Human Clinical Trials

All interventional evidence comes from mouse models; human data only confirms endogenous MOTS-c is exercise-responsive.

Read Full Deep Dive

Mechanism, dosing, vendor pricing, and full research citations

The Peptide Digest

Stay ahead of the market

New peptide profiles, vendor pricing shifts, and research updates. No spam, unsubscribe anytime.